Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
FK506 analog; calcineurin inhibitor.
STING agonist
Inhibitor of glutamic acid decarboxylase (GAD)....
LRRK2 inhibitor.
Triazole; demethylation inhibitor, NMDA agonist...
Endogenous peptide fragment, involved in vasoco...
Red-orange terpene pigment found in various pla...
EGFR, VEGFR inhibitor.
c-MET inhibitor.
Targets nuclear factor kappa B activation.
AR antagonist.
Oxazolidone derivative; Factor Xa inhibitor.
Selective inhibitor of LRRK2.
Casein kinase 2 inhibitor.
Peptide found in amphibians.
Alkaloid originally found in species of Nicotia...
Pyrimidine analog; inhibits thymidylate synthas...
Triazole; 14-α demethylase inhibitor.
mTOR inhibitor.
D-amino acid, incorporated into bacterial cell ...